Cargando…

Oligomeric tau-targeted immunotherapy in Tg4510 mice

BACKGROUND: Finding ways to reverse or prevent the consequences of pathogenic tau in the brain is of considerable importance for treatment of Alzheimer’s disease and other tauopathies. Immunotherapy against tau has shown promise in several mouse models. In particular, an antibody with selectivity fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroeder, Sulana, Joly-Amado, Aurelie, Soliman, Ahlam, Sengupta, Urmi, Kayed, Rakiz, Gordon, Marcia N., Morgan, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488475/ https://www.ncbi.nlm.nih.gov/pubmed/28655349 http://dx.doi.org/10.1186/s13195-017-0274-6

Ejemplares similares

LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice
por: Lee, Daniel C, et al.
Publicado: (2010)

Late neurodegeneration in the Tau transgenic mouse model rTg4510
por: Helboe, Lone, et al.
Publicado: (2013)

Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
por: Song, Lixin, et al.
Publicado: (2015)

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice
por: Anglada‐Huguet, Marta, et al.
Publicado: (2021)

Characterization of tau oligomeric seeds in progressive supranuclear palsy
por: Gerson, Julia E, et al.
Publicado: (2014)

Differential accumulation of tau pathology between reciprocal F1 hybrids of rTg4510 mice
por: Yanagisawa, Daijiro, et al.
Publicado: (2021)

Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice
por: Gamache, Julia, et al.
Publicado: (2019)

Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy
por: Takaichi, Yuta, et al.
Publicado: (2020)

Tau Causes Synapse Loss without Disrupting Calcium Homeostasis in the rTg4510 Model of Tauopathy
por: Kopeikina, Katherine J., et al.
Publicado: (2013)

Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
por: Wang, Xiaohai, et al.
Publicado: (2018)

In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line
por: Sahara, Naruhiko, et al.
Publicado: (2017)

Lion’s Mane (Hericium erinaceus) Exerts Anxiolytic Effects in the rTg4510 Tau Mouse Model
por: Rodriguez, Mya N., et al.
Publicado: (2022)

Study of tau pathology in male rTg4510 mice fed with a curcumin derivative Shiga-Y5
por: Yanagisawa, Daijiro, et al.
Publicado: (2018)

Transfusion with Blood Plasma from Young Mice Affects rTg4510 Transgenic Tau Mice Modeling of Alzheimer’s Disease
por: Hernandez, Carlos M., et al.
Publicado: (2023)

Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β
por: Hole, Katriona L., et al.
Publicado: (2021)

Altered Tau Kinase Activity in rTg4510 Mice after a Single Interfaced CHIMERA Traumatic Brain Injury
por: Cheng, Wai Hang, et al.
Publicado: (2023)

Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
por: Hastings, Nicholas B., et al.
Publicado: (2017)

Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner
por: Polanco, Juan Carlos, et al.
Publicado: (2016)

rTg(Tau(P301L))4510 mice exhibit increased VGlut1 in hippocampal presynaptic glutamatergic vesicles and increased extracellular glutamate release
por: Taipala, Erika, et al.
Publicado: (2022)

Home cage measures of Alzheimer's disease in the rTg4510 mouse model
por: Barabas, Amanda J., et al.
Publicado: (2022)

Formation and Propagation of Tau Oligomeric Seeds
por: Gerson, Julia E., et al.
Publicado: (2013)

Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
por: Wang, Hong, et al.
Publicado: (2018)

Unilateral Focused Ultrasound-Induced Blood-Brain Barrier Opening Reduces Phosphorylated Tau from The rTg4510 Mouse Model
por: Karakatsani, Maria Eleni, et al.
Publicado: (2019)

Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
por: Blackmore, Thomas, et al.
Publicado: (2017)

Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
por: Bittar, Alice, et al.
Publicado: (2018)

Altered Brain Metabolome Is Associated with Memory Impairment in the rTg4510 Mouse Model of Tauopathy
por: Tondo, Mireia, et al.
Publicado: (2020)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
por: Gerson, Julia E., et al.
Publicado: (2018)

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer’s disease
por: Sengupta, Urmi, et al.
Publicado: (2018)

The Role of Amyloid-β Oligomers in Toxicity, Propagation, and Immunotherapy
por: Sengupta, Urmi, et al.
Publicado: (2016)

Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
por: Harrison, Ian F., et al.
Publicado: (2019)

Iso-α-Acids, the Bitter Components of Beer, Suppress Microglial Inflammation in rTg4510 Tauopathy
por: Ano, Yasuhisa, et al.
Publicado: (2018)

The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT– and rTg(P301L)4510 mouse models of Alzheimer's disease
por: Jimenez, Heidy, et al.
Publicado: (2022)

Effects of the C57BL/6 strain background on tauopathy progression in the rTg4510 mouse model
por: Bailey, Rachel M, et al.
Publicado: (2014)

Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer’s Disease
por: Gelman, Simon, et al.
Publicado: (2017)

Correction to: Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
por: Harrison, Ian F., et al.
Publicado: (2019)

Impaired Kv7 channel function in cerebral arteries of a tauopathy mouse model (rTg4510)
por: de Jong, Inge E. M., et al.
Publicado: (2018)

Enhancement of tripartite synapses as a potential therapeutic strategy for Alzheimer’s disease: a preclinical study in rTg4510 mice
por: Foster, Joshua B., et al.
Publicado: (2019)

Evidence against a contribution of the CCAAT-enhancer binding protein homologous protein (CHOP) in mediating neurotoxicity in rTg4510 mice
por: Criado-Marrero, Marangelie, et al.
Publicado: (2022)

Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies
por: Montalbano, Mauro, et al.
Publicado: (2022)

Polymorphic α-Synuclein Strains Modified by Dopamine and Docosahexaenoic Acid Interact Differentially with Tau Protein
por: Sengupta, Urmi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6jjber9gm7s6ljkd3f68cfscbf